About Vaasavaa Pharmaceuticals
Vaasavaa Pharmaceuticals is a company based in Hyderabad (India) founded in 2000. It operates as a B2B. The company has 67 employees as of March 31, 2023. Vaasavaa Pharmaceuticals offers products and services including Active Pharmaceutical Ingredients and Drug Intermediates. Vaasavaa Pharmaceuticals operates in a competitive market with competitors including Viyash, Inventys, Blue Jet Healthcare, Ami organics and Aparna Pharmaceuticals, among others.
- Headquarter Hyderabad, India
- Employees 67 as on 31 Mar, 2023
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
- Legal Name Vaasavaa Pharmaceuticals Private Limited
- Date of Incorporation 17 Jul, 2000
- Jurisdiction Solapur, Maharashtra, India
-
Annual Revenue
$4.41 M (USD)-51.27as on Mar 31, 2023
-
Net Profit
$70.75 K (USD)-79.93as on Mar 31, 2023
-
EBITDA
$796.49 K (USD)-36.57as on Mar 31, 2023
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
67
as on Mar 31, 2023
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Vaasavaa Pharmaceuticals
Vaasavaa Pharmaceuticals offers a comprehensive portfolio of products and services, including Active Pharmaceutical Ingredients and Drug Intermediates.
Produces APIs for use in drug formulations
Manufactures intermediates for API production
Funding Insights of Vaasavaa Pharmaceuticals
Detailed funding history for Vaasavaa Pharmaceuticals
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Vaasavaa Pharmaceuticals
Investment portfolio details for Vaasavaa Pharmaceuticals
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Vaasavaa Pharmaceuticals
Detailed financials for Vaasavaa Pharmaceuticals
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Vaasavaa Pharmaceuticals Comparisons
Peer comparison for Vaasavaa Pharmaceuticals
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Vaasavaa Pharmaceuticals
Vaasavaa Pharmaceuticals operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Viyash, Inventys, Blue Jet Healthcare, Ami organics and Aparna Pharmaceuticals, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
APIs and intermediates are manufactured by Viyash as a CDMO.
|
|
| Locked | Locked | Locked |
Actives, advanced intermediates, and specialty chemicals are custom manufactured.
|
|
| Locked | Locked | Locked |
CDMO focused on manufacturing, supplier, and development of intermediates & APIs
|
|
| Locked | Locked | Locked |
Advanced API intermediates are manufactured for pharmaceutical use.
|
|
| Locked | Locked | Locked |
API intermediates are manufactured by Aparna Pharmaceuticals as a CDMO.
|
|
| Locked | Locked | Locked |
CDMO focused on manufacturing of APIs and intermediates
|
Detailed competitors of Vaasavaa Pharmaceuticals
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Vaasavaa Pharmaceuticals
Complete news archive for Vaasavaa Pharmaceuticals
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Vaasavaa Pharmaceuticals
Vaasavaa Pharmaceuticals was founded in 2000.
Vaasavaa Pharmaceuticals is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
As of Mar 31, 2023, the latest employee count at Vaasavaa Pharmaceuticals is 67.
Annual revenue of Vaasavaa Pharmaceuticals is $4.41M as on Mar 31, 2023.
Vaasavaa Pharmaceuticals Private Limited specializes in developing and producing Active Pharmaceutical Ingredients (APIs) and their intermediates. The company operates a manufacturing facility in Solapur, Maharashtra, India, and a corporate office in Hyderabad, Telangana, India. It serves both domestic and international markets, adhering to WHO GMP and DCA GMP standards. Quality assurance activities include analysis of raw materials and products, while maintaining departments for production, warehouse, and maintenance to ensure compliance and efficiency.
Vaasavaa Pharmaceuticals's top competitors include Inventys, Viyash and Blue Jet Healthcare.
Vaasavaa Pharmaceuticals offers Active Pharmaceutical Ingredients and Drug Intermediates.